PHIO
Phio Pharmaceuticals Corp.
NASDAQ · Healthcare · Biotechnology · US
$0.87
−0.25%Margins
Gross margin
—
EBITDA margin
—
EBIT margin
—
Net margin
—
FCF margin
—
-102.4%
Return on equity
-90.2%
Return on assets
-106.9%
Return on invested capital
0.00x
Asset turnover
-$12.2M
Cash from operations
$1.12
Cash per share
Margins, returns on capital and operating efficiency from the latest trailing period · Data as of Jun 1, 2026